Development of Novel Antibiotic Lysocin E Identified by Silkworm Infection Model.
Development of Novel Antibiotic Lysocin E Identified by Silkworm Infection Model.
Yakugaku Zasshi. 2017;137(4):389-392
Authors: Hamamoto H, Sekimizu K
Abstract
In this symposium, we reported the identification and mechanistic analysis of a novel antibiotic named lysocin E. Lysocin E was identified by screening for therapeutic effectiveness in a silkworm Staphylococcus aureus infection model. The advantages of the silkworm infection model for screening and purification of antibiotics from the culture supernatant of soil bacteria are: 1) low cost; 2) no ethical issues; 3) convenient for evaluation of the therapeutic effectiveness of antibiotics; and 4) pharmacokinetics similar to those of mammals. Lysocin E has remarkable features compared with known antibiotics such as a novel mechanism of action and target. Here, we summarize our reports presented in this symposium.
PMID: 28381711 [PubMed - in process]
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - Category: Drugs & Pharmacology Authors: Hamamoto H, Sekimizu K Tags: Yakugaku Zasshi Source Type: research
More News: Medical Ethics | Staphylococcus Aureus